Probiotics: overview of microbiological and immunological characteristics

References

• Metchnikoff E. Lactic acid as inhibiting intestinal putrefaction. In: The Prolongation of Life Optimistic Studies. Heinemman W (Ed.). London, UK 161–183 (1907).
   Google Scholar
• Lilly DM, Stillwell RM. Probiotics: growth promoting factors produced by microorganisms. Science147, 747–748 (1965).
   PubMed Web of Science ®Google Scholar
• Füller R. Probiotics in man and animals. J. Appl. Bacteriol.66, 365–378 (1989).
   PubMedGoogle Scholar
• Guarner F, Schaafsma GJ. Probiotics. Int. J. Food Microbiol.39, 237–238 (1998).
   PubMed Web of Science ®Google Scholar
• Joint FAO/WHO Expert Consultation. Health and Nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Joint FAO/WHO Expert Consultation, Cordoba, Argentina, 1–4 October 2001.
   Google Scholar
• Guidelines for the evaluation of probiotics in food: Joint FAO/WHO Working Group meeting, London, UK, ON, Canada, 30 April–1 May, 2002.
   Google Scholar
• Guarner F, Malagelada JR. Gut flora in health and disease. Lancet361, 512–519 (2003).
   PubMed Web of Science ®Google Scholar
• Saarela M, Mogensen G, Fondén R, Mättö J, Mattila-Sandholm T. Probiotic bacteria: safety, functional and technological properties. J. Biotechnology84, 197–215 (2000).
   PubMed Web of Science ®Google Scholar
• Reid G, Jass J, Sebulsky MT, McCornick JK. Potential uses of probiotics in clinical practice. Clin. Microbiol. Rev.16(4), 658–672 (2003).
   PubMed Web of Science ®Google Scholar
• Mercenier A, Pavan S, Pot B. Probiotics as biotherapeutic agents: present knowledge and future prospects. Curr. Pharm. Des.9(2), 175–191 (2003).
   PubMed Web of Science ®Google Scholar
• O’Hara AM, Shanahan F. Mechanisms of action of probiotics in intestinal diseases. ScientificWorldJournal7, 31–46 (2007).
   PubMedGoogle Scholar
• Del Piano M, Morelli L, Strozzi GP et al. Probiotics: from research to consumer. Dig. Liver. Dis.38(Suppl.2), S248–S255 (2006).
   Google Scholar
• Parvez S, Malik KA, Ah Kang S, Kim HY. Probiotics and their fermented food products are beneficial for health. J. Appl. Microbiol.100, 1171–1185 (2006).
   PubMed Web of Science ®Google Scholar
• Holzapfel WH, Schillinger U. Introduction to pre- and probiotics. Food Res. Int.35, 109–116 (2002).
   Web of Science ®Google Scholar
• Falagas ME, Betsi GI, Athanasiou S. Probiotics for the treatment of women with bacterial vaginosis. Clin. Microbiol. Infect.13, 657–664 (2007).
   PubMed Web of Science ®Google Scholar
• Savage DC, Dubos R, Schaedler RW. The gastrointestinal epithelium and its autochthonous bacterial flora. J. Exp. Med.127, 67–76 (1968).
   PubMed Web of Science ®Google Scholar
• Bjursell MK, Martens EC, Gordon JI. Functional genomic and metabolic studies of the adaptations of a prominent adult human gut symbiont, Bacteroides thetaiotaomicron, to the suckling period. J. Biol. Chem.281 (47), 36269–36279 (2006).
   PubMed Web of Science ®Google Scholar
• Rastall RA. Bacteria in the gut: friends and foes and how to alter the balance. J. Nutr.134, S2022–S2026 (2004).
   PubMed Web of Science ®Google Scholar
• Walter J. The microecology of lactobacilli in the gastrointestinal tract. In: Probiotics and Prebiotics Scientific Aspects. Tannock GW (Ed.). Caister Academic Press, London, UK 51–82 (2005).
   Google Scholar
• Brook I. Bacterial interference. Crit. Rev. Microbiol.25, 155–172 (1999).
   PubMed Web of Science ®Google Scholar
• Zoetendal EG, Collier CT, Koike S, Mackie RI, Gaskins HR. Molecular ecological analysis of the gastrointestinal microbiota: a review. J. Nutr.134, 465–472 (2004).
   PubMed Web of Science ®Google Scholar
• Haller D. Molecular interactions of commensal enteric bacteria with the intestinal epithelium and the mucosal immune system: implication for chronic intestinal inflammation. In: Probiotics and Prebiotics Scientific Aspects. Tannock GW (Ed). Caister Academic Press, London, UK 129–154 (2005).
   Google Scholar
• Haller D, Jobin C. Interaction between resident luminal bacteria and the host: can a healthy relationship turn sour? J. Pediatr. Gastroenterol. Nutr.38, 123–136 (2004).
   PubMed Web of Science ®Google Scholar
• Kelly D, Campbell JI, Knig TP et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear–cytoplasmatic shuttling of PPAR-g and ReIA. Nat. Immunol.5, 104–112 (2004).
   PubMed Web of Science ®Google Scholar
• Holzapfel WH, Haberer P, Snel J, Schillinger U, Huis in’t Veld JH. Overview of gut flora and probiotics. Int. J. Food Microbiol.41, 85–101 (1998).
   PubMed Web of Science ®Google Scholar
• Sanders ME, Guarner F, Mills D et al. Selected topics in probiotics and prebiotics: meeting report for the 2004 International Scientific Association for Probiotics and Prebiotics. Curr. Issues Intest. Microbiol.6, 55–68 (2005).
   PubMedGoogle Scholar
• Calder PC, Krauss-Etschmann S, de Jong EC et al. Early nutrition and immunity – progress and perspectives. Br. J. Nutr.96, 774–790 (2006).
   PubMed Web of Science ®Google Scholar
• Blümer N, Pfefferle PI, Renz H. Development of mucosal immune function in the intrauterine and early postnatal environment. Curr. Opin. Gastroenterol.23, 655–660 (2007).
   PubMed Web of Science ®Google Scholar
• Kelly D, Coutts AG. Early nutrition and the development of immune function in the neonate. Proc. Nutr. Soc.59(2), 177–185 (2000).
   PubMed Web of Science ®Google Scholar
• Garrity GM, Bell JA, Lilburn TG. Taxonomy outline of the prokaryotes. In: Bergey’s Manual of Systematic Bacteriology (2nd Edition). Garrety GM (Ed.). Spring Verlag, NY, USA (2004).
   Google Scholar
• Dellaglio F, Felis GE. Taxonomy of lactobacilli and bifidobacteria. In: Probiotics and Prebiotics Scientific Aspects. Tannock GW (Ed.). Caister Academic Press, London, UK 2, 25–49 (2005).
   Google Scholar
• Bernadeau M, Vernoux JP, Henri-Dubernet S, Guéguen M. The Lactobacillus genus. Int. J. Food Microbiol. DOI: 10.1016/jijfoodmicro.2007.08.015 (2007) (Epub ahead of print).
   Google Scholar
• Yeung PS, Kitts CL, Cano R, Tong PS, Sanders ME. Application of genotypic and phenotypic analysis to commercial probiotic strain identify and relatedness. J. Appl. Microbiol.97, 1095–1104 (2004).
   PubMed Web of Science ®Google Scholar
• Huys G, Vancanney M, D’Haene K, Vankerckhoven V, Goussens H, Swing J. Accuracy of species identity of commercial bacterial cultures intended for probiotic or nutritional use. Res. Microbiol.157, 803–810 (2006).
   PubMed Web of Science ®Google Scholar
• Holzapfel WH, Haberer P, Geisen R, Björkroth J, Schillinger U. Taxonomy and important features of probiotic microrganisms in food and nutrition. Am. J. Clin. Nutr.73(Suppl.), S365–S373 (2001).
   PubMed Web of Science ®Google Scholar
• Morelli L. Probiotics: clinics and/or nutrition. Dig. Liver Dis.34(Suppl. 2) S8–S11 (2002).
   Google Scholar
• Gorbach SL. Probiotics in the third millennium. Dig. Liver Dis.34(Suppl. 2), S2–S7 (2002).
   Google Scholar
• Douglas LC, Sanders ME. Probiotics and prebiotics in dietetics practice. J. Am. Diet. Assoc.108(3), 510–521 (2008).
   PubMed Web of Science ®Google Scholar
• Marteau P, Shanahan F. Basic aspects and pharmacology of probiotics: an overview of pharmacokinetics, mechanisms of action and side-effects. Best Pract. Res. Clin. Gastroenterol.17, 725–740 (2003).
   PubMed Web of Science ®Google Scholar
• Rastall RA, Gibson GR, Gill HS et al. Modulation of the microbial ecology of the human colon by probiotics, prebiotics and synbiotics to enhance human health: an overview of enabling science and potential applications. FEMS Microbiol. Ecol.52, 145–152 (2005).
   PubMed Web of Science ®Google Scholar
• Princivalli MS, Paoletti C, Palmieri L et al. Antagonistic activity of Lactobacillus rhamnosus GG against cell invasion by macrolide- and tetracycline-resistant group A streptococci. Proceedings of the 4th Probiotics and Prebiotics New Food jointly with XXX International Congress on Microbiological Ecology and Disease (SOMED), Rome, Italy 3 (2007).
   Google Scholar
• Gill HS. Probiotics to enhance anti-infective defences in the gastrointestinal tract. Best Pract. Res. Clin. Gastroenterol.17, 755–733 (2003).
   PubMed Web of Science ®Google Scholar
• Candela M, Seibold G, Vitali B, Lachenmaier S, Eikmanns BJ, Brigidi P. Real time PCR quantification of bacterial adhesion to Caco-2 cells: competition between bifidobacteria and enteropathogens. Res. Microbiol.156(8), 887–895 (2005).
   PubMed Web of Science ®Google Scholar
• Ljungh A, Wadstrom T. Lactic acid bacteria as probiotics. Curr. Issues Intest. Microbiol.7(2), 73–89 (2006).
   PubMedGoogle Scholar
• Sonnenburg JL, Chen CTL, Gordon JI. Genomic and metabolic studies of the impact on a model gut symbiont and host. PLoS Biol.4, 2213–2226 (2006).
   Web of Science ®Google Scholar
• Corthésy B, Gaskins HR, Mercenier A. Cross-talk between probiotic bacteria and the host immune system. J. Nutr.137(3 Suppl. 2), S781–S790 (2007).
   PubMed Web of Science ®Google Scholar
• Salminen MK, Rautelin H, Tynkkynen S et al. Lactobacillus bacteraemia, species identification, and antimicrobial susceptibility of 85 blood isolates. Clin. Infect. Dis.42(5), 35–44 (2006).
   Web of Science ®Google Scholar
• Besselink M, Van Santvoort HC, Buskens E et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomized, double-blind, placebo controlled trial. Lancet371, 651–659 (2008).
   PubMed Web of Science ®Google Scholar
• Morelli L, Matto J, Wilcks A, Aarts HJM, Bolton D. EU Project. ACE-ART EU project. Healthgrain NUTRAfoods4(2/3), (2005).
   Google Scholar
• Mathur S, Singh R. Antibiotic resistance in food lactic acid bacteria – a review. Int. J. Food Microbiol.105, 281–295 (2005).
   PubMed Web of Science ®Google Scholar
• Hummel AS, Hertel C, Holzapfel WH, Franz CM. Antibiotic resistances of starter and probiotic strains of lactic acid bacteria. Appl. Environ. Microbiol.73, 790–739 (2007).
   Google Scholar
• European Commission Opinion of the FEEDAP. Panel on updating of the criteria used in the assessment of bacteria for resistance to antibiotics of human or veterinary importance. EFSA223, 1–12 (2005).
   Google Scholar
• Danielsen M, Wind A. Susceptibility of Lactobacillus spp. to antimicrobial agents. Int. J. Food Microbiol.82, 1–11 (2003).
   PubMed Web of Science ®Google Scholar
• Temmermann R, Pot B, Huys G, Swings J. Identification and antibiotic susceptibility of bacterial isolates from probiotic products. Int. J. Food Microbiol.81, 1–10 (2003).
   PubMed Web of Science ®Google Scholar
• Delgado S, Florez AB, Mayo B. Antibiotic susceptibility of Lactobacillus and Bifidobacterium species from human gastrointestinal tract. Curr. Microbiol.50, 202–207 (2005).
   PubMed Web of Science ®Google Scholar
• Milazzo I, Speciale A, Musumeci R, Fazio D, Blandino G. Identification and antibiotic susceptibility of bacteria isolates from probiotic products available in Italy. New Microbiol.29, 281–291 (2006).
   PubMed Web of Science ®Google Scholar
• Florez AB, Egervärn M, Danielsen M et al. Susceptibility of Lactobacillus plantarum strains to six antibiotics and definition of new susceptibility resistance cutoff values. Microb. Drug Resist.12, 252–256 (2006).
   PubMed Web of Science ®Google Scholar
• Ammor MS, Florez AB, Mayo B. Antibiotic resistance in non-enterococcal lactic acid bacteria and bifidobacteria. Food Microbiol.24, 559–570 (2007).
   PubMed Web of Science ®Google Scholar
• Aquilanti L, Garofalo C, Osimani A, Silvestri G, Vignaroli C, Clementi F. Isolation and molecular characterization of antibiotic resistant lactic acid bacteria from poultry and swine meat products. J. Food Prot.70(3), 557–565 (2007).
   PubMed Web of Science ®Google Scholar
• Blandino G. Antibiotic susceptibility of bacterial isolates from probiotic products available in Italy. Proceedings of the 4th Probiotics and Prebiotics New Food jointly with XXX International Congress on Microbiological Ecology and Disease (SOMED), Rome, Italy I, 3 (2007).
   Google Scholar
• D’Aimmo MR, Modesto M, Biavati B. Antibiotic resistance of lactic acid bacteria and Bifidobacterium spp. isolated from dairy and pharmaceutical products. Int. J. Food Microbiol.115, 35–42 (2007).
   PubMed Web of Science ®Google Scholar
• Flórez AB, Ammor MS, Mayo B, van Hoek AH, Aarts HJ, Huys G. Antimicrobial susceptibility profiles of 32 types strains of Lactobacillus, Bifidobacterium, Lactococcus and Streptococcus spp. Int. J. Antimicrob. Agents31, 484–486 (2008).
   PubMed Web of Science ®Google Scholar
• Klare I, Konstabel C, Werner G et al. Antimicrobial susceptibilities of Lactobacillus, Pediococcus and Lactococcus human isolates and cultures intended for probiotic or nutritional use. J. Antimicrob. Chemother.59, 900–912 (2007).
   PubMed Web of Science ®Google Scholar
• Kastner S, Perreten V, Bleuler H, Hugenschmidt G, Lacroix C, Meile L. Antibiotic susceptibility patterns and resistance genes of starter cultures and probiotic bacteria used in food. Syst. Appl. Microbiol.29(2), 145–155 (2006).
   PubMed Web of Science ®Google Scholar
• Masco L, Van Hoorde K, De Brandt E, Swings J, Huys G. Antimicrobial susceptibility of Bifidobacterium strains from humans, animal and probiotic products. J. Antimicrob. Chemother.58, 85–94 (2006).
   PubMed Web of Science ®Google Scholar
• Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Supplements M100-S16. Clinical and Laboratory Standards Institute, Wayne, PA, USA (2006).
   Google Scholar
• Foligne B, Nutten S, Grangette C et al. Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World J. Gastroenterol.13(2), 236–243 (2007).
   PubMed Web of Science ®Google Scholar
• Sanders ME, Tompkins T, Heimbach JT, Kolida S. Weight of evidence needed to substantiate a health effect for probiotics and prebiotics. Regulatory considerations in Canada, E.U., and U.S. Eur. J. Nutr.44, 303–310 (2005).
   PubMed Web of Science ®Google Scholar
• Kaur IP, Chopra K, Saini A. Probiotics: potential pharmaceutical applications. Eur. J. Pharm. Sci.15, 1–9 (2002).
   PubMed Web of Science ®Google Scholar
• Ouwehand AC, Salminen S, Isolauri E. Probiotics: an overview of beneficial effects. Antonie Van Leeuwenhock82, 279–289 (2002).
   PubMed Web of Science ®Google Scholar
• Huff BA. Caveat emptor “probiotics” might not be what they seem. Can. Fam. Physician50, 583–587 (2004).
   PubMed Web of Science ®Google Scholar
• Huys G, Vancanney M, Haene K et al. Accurancy of species identity of commercial bacterial cultures intended for probiotic or nutrional use. Res. Microbiol.157, 803–810 (2006).
   PubMed Web of Science ®Google Scholar
• Hong HA, Due LM, Cutting SM. The use of bacterial spore formers as probiotics. FEMS Microbiol. Rev.29, 813–835 (2005).
   PubMed Web of Science ®Google Scholar
• Cagler E, Kargul B, Tanboga I. Bacteriotherapy and probiotics role on oral health. Oral Dis.11, 131–137 (2005).
   PubMed Web of Science ®Google Scholar
• Meurman JH, Stamatova I. Probiotics: contribution to oral health. Oral Dis.13, 443–451 (2007).
   PubMed Web of Science ®Google Scholar
• Guarino A, Canani RB, Spagnuolo MI, Albano F, Di Benedetto L. Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea. J. Pediatr. Gastroenterol. Nutr.25, 516–519 (1997).
   PubMed Web of Science ®Google Scholar
• Sleator RD, Hill C. Probiotics as therapeutics for the developing world. J. Infect. Developing Countries1, 7–12 (2007).
   Google Scholar
• Casey PG, Gardiner GE, Casey G et al. A five strain probiotic combination reduced pathogen shedding and alleviates disease signs in pigs challenged with Salmonella enterica serovar thyphimurium. Appl. Environ. Microbiol.73, 1858–1863 (2007).
   PubMed Web of Science ®Google Scholar
• Manzoni P, Mostert M, Leonessa ML et al. Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study. Clin. Infect. Dis.42(12), 1735–1742 (2006).
   PubMed Web of Science ®Google Scholar
• Limdi JK, O’Neill C, McLaughlin J. Do probiotics have a therapeutic role in gastroenterology? World J. Gastroenterol.12(34), 5447–5457 (2006).
   PubMed Web of Science ®Google Scholar
• Johnston BC, Supina AL, Vohra S. Probiotics for pediatric antibiotic-associated diarrhea: a meta-analysis of randomized placebo-controlled trials. CMAJ175, 377–383 (2006).
   PubMed Web of Science ®Google Scholar
• Hamilton-Miller JM. The role of probiotics in the treatment and prevention of Helicobacter pylori infection. Int. J. Antimicrob. Agents22, 360–366 (2003).
   PubMed Web of Science ®Google Scholar
• Brook I. Microbiology and management of neonatal necrotizing enterocolitis. Am. J. Perinatol.25(2), 111–118 (2008).
   PubMed Web of Science ®Google Scholar
• Lammers KM, Brigidi P, Vitali B et al. Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunol. Med. Microbiol.38, 165–172 (2003).
   PubMed Web of Science ®Google Scholar
• Hoentjen F, Tonkonogy SL, Qian BF, Liu B, Dieleman LA, Sartor RB. CD4+ T lymphocytes mediate colitis in HLA-B27 transgenic rats monoassociated with nonpathogenic Bacteroides vulgatus. Inflamm. Bowel Dis.13, 317–324 (2007).
   PubMed Web of Science ®Google Scholar
• Peran L, Camuesco D, Comalada M et al. A comparative study of the preventative effects exerted by three probiotics, Bifidobacterium lactis, Lactobacillus casei and Lactobacillus acidophilus, in the TNBS model of rat colitis. J. Appl. Microbiol.103, 836–844 (2007).
   PubMed Web of Science ®Google Scholar
• Peran L, Sierra S, Comalada M et al. A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis. Br. J. Nutr.97, 96–103 (2007).
   PubMed Web of Science ®Google Scholar
• Lorea Baroja M, Kirjavainen PV, Hekmat S, Reid G. Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients. Clin. Exp. Immunol.149, 470–479 (2007).
   PubMed Web of Science ®Google Scholar
• Fedorak RN, Madsen KL. Probiotics and the management of inflammatory bowel disease. Inflamm. Bowel Dis.10, 286–299 (2004).
   PubMed Web of Science ®Google Scholar
• Allez M, Mayer L. Regulatory T cells: peace keepers in the gut. Inflamm. Bowel Dis.10, 666–676 (2004).
   PubMed Web of Science ®Google Scholar
• Zigra PI, Maipa VE, Alamanos YP. Probiotics and remission of ulcerative colitis: a systematic review. Neth. J. Med.65, 411–418 (2007).
   PubMed Web of Science ®Google Scholar
• Rakoff-Nahoum S, Medzhiton R. Regulation of spontaneous intestinal tumorogenesis through the adaptor protein MyD 88. Science317, 124–127 (2007).
   PubMed Web of Science ®Google Scholar
• Parks TP, Xu Q, Lagenaur LA et al. Bacterial therapeutics for the treatment and prevention of urogenital infections. In: Probiotics and Prebiotics Scientific Aspects. Tannock GW (Ed.). Caister Academic Press, London, UK 8, 171–194 (2005).
   Google Scholar
• Falagas ME, Betsi GI, Tokas T, Athanasiou S. Probiotics for prevention of recurrent urinary tract infections in women: a review of the evidence from microbiological and clinical studies. Drugs66(9), 1253–1261 (2006).
   PubMed Web of Science ®Google Scholar
• Reid G, Charbonneau D, Erb J et al. Oral use of Lactobacillus rhamnosus GR-1 and L.fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol. Med. Microbiol.35, 131–134 (2003).
   PubMed Web of Science ®Google Scholar
• Falagas ME, Betsi GI, Athanasiou S. Probiotics for prevention of recurrent vulvovaginal candidiasis: a review. J. Antimicrob. Chemother.58(2), 266–272 (2006).
   PubMed Web of Science ®Google Scholar
• Betsi GI, Papadavid E, Falagas ME. Probiotics for the treatment or prevention of atopic dermatitis: a review of the evidence from randomized controlled trials. Am. J. Clin. Dermatol.9, 93–103 (2008).
   PubMed Web of Science ®Google Scholar
• Scheneider SM, Griard-Pipau F, Filippi J et al. Effects of Saccharomyces boulardii on fecal short-chain fatty acids and microflora in patients on long-term total enteral nutrition. World J. Gastroenterol.11(39), 6165–6169 (2005).
   PubMed Web of Science ®Google Scholar
• Steidler L and Neirynck S. Genetically modified probiotics. In: Probiotics and Prebiotics Scientific Aspects. Tannock GW (Ed.). Caister Academic Press, London, UK 7, 154–170 (2005).
   Google Scholar
• Steidler L, Neirynck S, Huyghebaert N et al. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nat. Biotechnol.21, 785–789 (2003).
   PubMed Web of Science ®Google Scholar